JPMorgan Chase Downgrades Munich Re and Hannover Rück
JPMorgan Chase analysts downgraded Munich Re and Hannover Rück, citing concerns over future pricing pressure in the reinsurance sector.
Stocks · News reference
JPMorgan Chase Discloses Stake in Evotec SE
JPMorgan Chase & Co. reported that it has crossed the 3% voting rights threshold in the biotechnology company Evotec SE.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
JPMorgan Chase Upgrades Sociedad Química y Minera de Chile S.A.
JPMorgan Chase has upgraded its rating for Sociedad Química y Minera de Chile S.A. to 'Buy'.
JPMorgan Chase Discloses Voting Rights Change in LANXESS AG
JPMorgan Chase & Co. filed a regulatory notification regarding a change in its voting rights in German specialty chemicals company LANXESS AG.
JPMorgan Chase Reaffirms Neutral Rating on Microchip Technology
JPMorgan Chase maintained its neutral rating on Microchip Technology Incorporated in an analyst update reported on November 6, 2026.
JPMorgan Chase Increases Stake in Bodycote plc
JPMorgan Chase & Co. reported an increase in its voting rights position in Bodycote plc to 10.003914%.
JPMorgan Chase Bank Acts as Sole Arranger for $500 Million Debt Financing
JPMorgan Chase Bank, N.A. served as the sole arranger for $500 million in debt financing to support Shield's $5.3 billion acquisition of Echodyne Corp.